that you, Thank Marrone have at families pipeline at greater We years of develop leveraged with growth than revenue blended leading of proven Bio a have rate, generated XX% our annual five to five XX%. margins Jim. compound industry current R&D products
and flexible natural our based bio significant value across products farming to practices growers. add Our are
an market be are products to combined products boost existing the unmet used of Our an effectiveness existing the tandem to positioned or in technology to alternative program. address needs, with as to serve uniquely
we operations XXXX, we As expanded margin. our footprint and financial Jim as gross noted, grew commercial revenues we not in only and so did stabilized
for financially to and more into months a two than growth are commercially put and XXXX, this beyond. revenue have XXXX year we a technically, growth we us, pivotal drive year in Now in stage place, and foundation for the solid set
and three in are One three accelerated key two We focused expansion market innovation. on portfolio optimization, XXXX. deliverables
to If of optimization. slide let's five, portfolio example an turn you at look would
optimizing and flexible unmet by are portfolio expanded geographies, across We with an our of size and on set in needs market practices. focused programs are that crops farm addressing
came nematode know, from internal the of discovery you a may as R&D Majestene for treatment program. our As
through an to and looked has cotton. that great team and of how be is including and nematode portfolio on that we found soybeans this that and bacterial example soil States seed expect Our invested productivity make deployed a initial now insecticide backbone we our optimization. family leverage fermentation used the offering R&D The led it capital the treatment, of and effective acres it products in this Venerate of our at of United year is corn, maximize the properties of Venerate to which raw millions also crops
plans with geographic United only in and outside Europe Asia, for This the seed work to reach, and specialty but America move include to expand distribution are products, not we we includes States our As and looking forward, expansions expansion expand well. applied as our internationally crops United States. into underway treatment network South soil the
our further We Majestene super formulation with step this are investment our portfolio taking one optimization in nematicide. year of the
the opportunity the the to We options costs the rate growing focus improved for applied process Majestene forward. and going the percentage level. to is as a lower significant be us portfolio year key products product has farmers application the the look The with in Therefore, significantly fermentation new a their for franchise market potential manufacturing this are soil as potential and is reduce have practices. of developing of at production seed of that optimization grower
example Almond of second of it $X.XX XX% bearing pound offerings we value significant to have X,XXX offerings six historically growers the the pounds We grown that common pest opportunity conventional to became it per through first add will the almond grown enhance California, management $X crop bio with Our opportunity of to with apparent an share globally, solution our chemical we value a acre. quickly our generating with high fungus be California biological our crop is in highlights production face, X.X with in expand market expand products slide market used yield acres footprint quality. is some could crop than based to here are an current our million an expand and has industry, systems how and almond growers expansion, average treat market more per roughly yields, bio integrated that of program. problems new our the their footprint solutions that new REGALIA seed to production with to almonds integrated into entered product end based
and are of with sales The them introductions on insect here can manage growers acre. expanding market growing Venerate heat With almond give our multiple and working the and same we're Haven increased products given is now multiple that margin orchards their and season, into in applications Venerate with California, to the Haven to season reach for in stress. demonstrate have yield. coming opportunities We the marketable full-bore and our growing control we of
full expanding suite into is multiple be move we'll the our XXXX. acre Selling market of sales into the that one our products market our we this same of expansion expect of opportunities. as on We products example
the resistance, into properties. our didn't pipeline an taking example we to microbe. has fact, our we And three of further, broad-leaf growers product, in would I'd market time is offering are a in could I technology program. base of herbicide slide found there. solution. herbicide broad-leaf to by product you the the when number markets how expanding million library key out additional from use drive optimize we application emergent turn They to post you accelerating as making for introduction have and are like approximately bio-based in products and first with herbicidal in the call, cotton be pipeline a how market, if This MBI-XXX, the At has a the investments it and an and control but we mentioned other weed row leverage like crop the in weed year organic we target million XXX step Venerate as to in acres of broad respectively. seven, stop are previously innovation Finally, we this through By herbicides, MBI-XXX MIB-XXX and MBI-XXX testing challenged that applications pre give unique available unique that we combination treatment. in is well which soybeans weed bacterial one developed one fermentation a Majestene, disruptive the increasingly potential XX are be as market. breakthrough both for globally, a
We been product, and composition additional both for use with have granted this of filed. unique method patents patents
regulatory Our of August made first XXXX. was submission in EPA
necessary Given the compiling opportunity, we size testing the additional are accelerated in and investment commercialization of of mentioned, in an for Jim XXXX this accelerate the budgeting MBI-XXX as data an and ramp. to
points slide the opportunity the prudent I'd have increase additional believe investment. Jim While we expenses will you turn to is if to this like worth this a unique we that reiterate closing, operating that in In emphasized. XXXX, eight, with product would
place, from solutions with the for the accelerate XXXX in have leadership to leverage stage in With significant bio-based agriculture, our to set Bio's we groundwork growth. opportunities Marrone
year-over-year expect launching Bio's our approach by to accelerated optimization, and products. expansion, We successes strategically capitalizing commercial a summary, are our by innovation by technical growth In revenues complemented substantial pipeline market portfolio in Marrone portfolio. in R&D disciplined and the product investing
focused Coupled leader well are the bio-based We cash like of efficiency on we as commercial our in improving last call your solutions. to we'd the refinancing to judiciously. manufacturing year's and the and up investing At are questions. strategically agricultural point, open this company, positioned with
